Membrana celular y la inespecificidad de las nanopartículas. ¿Hasta dónde puede llegar un nanomaterial dentro de la célula?
Resumen
Resumen:
En la actualidad, estamos en contacto con una gran variedad de nanopartículas de uso industrial ya sea como residuo por los procesos de manufactura o como los empleados en productos de uso cotidiano. Estos inevitablemente entraran en el organismo atravesando diversas barreras naturales (como la piel o los epitelios intestinales o respiratorios) e interactuaran con diferentes tipos de células. Los mecanismos de interacción son tan variados e incluso pueden verse influenciados en función del tipo de nanoparticula y su naturaleza química.
Abstract
Nowadays we are in direct contact to different sort of industrial nanoparticles, which can be produced either consequence of manufacture process or incorporated to products of personal use. They finally go into organism through skin or epithelium (intestinal or alveolar). The cell´s interaction can be influenced by nanoparticle properties such as shape, size and chemical composition.
Citas
Applequist S. E., Wallin R. P., Ljunggren H. G. (2002). Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol, sept., 14(9): 1065-74.
Arvizo, R. R., Miranda, O. R., Thompson, M. A., Pabelick, C. M., Bhattacharya, R., Robertson, J. D. y Mukherjee, P. (2010). Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano letters, 10(7): 2543-2548.
Bigay Joelle y Antonny Bruno (2012). Curvature, lipid packing and electrostatics of membrane organelles: Defining cellular territories in determining specificity. Developmental Cell, 23(13): 886-895.
Chairuangkittia P., Lawanpraserta S., Roytrakulb S., Aueviriyavitc S., Phummiratchc D., Kulthongc K., Chanvorachotea P., Maniratanachote R. (2013). Silver nanoparticles induce toxicity in A459 cells via ROS–dependent and ROS–independent pathways. Toxicity in vitro, 27(1): 330-338.
Cho K., Wnag X., Nie S., Chen Z., Shin D. (2008). Therapeutic nanoparticles for drug delivery in cancer. Clinical Cancer Research, 14(5): 1310-1316.
Costa, D., Costa, C., Caldeira, M., Cortes, L., Queiroz, J. A., y Cruz, C. (2017). Targeting of cellular organelles by fluorescent plasmid DNA nanoparticles. Biomacromolecules, 18(9): 2928-2936.
De Volder et al, Carbon nanotubes: Present and future commercial applications. (2013) Science, 339: 535 539.
Dorsam R.T., Gukind J.S. (2007). G-protein coupled receptors and cancer. Nature reviews cancer, 7: 79-94.
Eidukaite A., Tamosiunas V. (2004). Endometrial and peritoneal macrophages: Expression of activation and adhesion molecules. Am. J. Reprod. Immunol., ag., 52(2): 113-7.
Ershova E. S., Sergeeva V. A., Chausheva A. I., Zheglo D. G., Nikitina V. A., Smirnova T. D., Kameneva L. V., Porokhovnik L. N., Kutsev S. I., Troshin P. A., Voronov I. I., Khakina E. A., Kostyuk S. V. (2016). Toxic and dna damaging effects of a functionalized fullerene in human embryonic lung fibroblasts. Mutational Research/ Genetic Toxicology and Environmental Mutagenesis, 85: 46-57.
Goñi F. M. (2014). The basic structure and dynamics of cell membranes: An update of the Singer-Nicolson model. Biochemica et Biophysica Acta.
Hild W., Pollinger K., Caporale A., Cabrele C., Keller M., Pluym N., Buschauer A., Rachel R., Tessmat J., Breunig M., Geopfeirch A., G. (201o). Protein-coupled receptors function as logic gates for nanoparticles binding and cell uptake. PNAS, 8(107): 23, 10667-10672.
Hussain S.M. Hess K.L: Gearthart J.M., Geiis K.T. Schlager J.J., (2005). In vitro toxicity of nanoparticles in BRL 3A rat liver cells.
Julius David, Livelli Thomas, Jessel Thomas M. y Axel Richard (1989). Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science, 244, 1057-1062.
Lankoff A., Arabski M., Wegierek-Ciuk A., Kruszewski M., Lisowska H., Banasik- Nowak A., Rozga–Wijas K., Wojewodzka M., Slomkowski S. (2013). Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro. Nanotoxicology, 7(3): 235-250.
Mironava T., Hadjiargyrou M., Simon M., Jurukovski V. (2010). Gold nanoparticles cellular toxicity and recovery: Effect of size, concentration and exposure. Nanotoxicology, 4(1): 120-137.
Mittal S and Pandey A. (2014). Cerium oxide nanoparticles induced toxicity in human lung cells: Role of ROS mediated DNA damage and apoptosis. BioMEd Research International, 1-14.
Monteith, G. R.; McAndrew, D.; Faddy, H. M.; Roberts-Thomson, S. J. (2007). Nature. Reviews Cancer, (7), 519-530.
Nabiev, I.; Mitchell, S.; Davies, A.; Williams, Y.; Kelleher, D.; Moore, R.; Gun’ko, Y. K.; Byrne, S.; Rakovich, Y. P.; Donegan, J. F. et al. (2007). Nonfunctionalized nanocrystals can exploit a cell’s active transport machinery delivering them to specific nuclear and cytoplasmic compartments. Nano Lett., 7: 3452-3461.
Nair L. S., Laurencin C. T. (2007). Silver nanoparticles: Synthesis and therapeutic applications. J. Biomed. Nanotechnol., 3: 301-316.
O’Hayre M., Degese M. S., Gutkind S. J. (2014). Novel insights into G protein and G protein-coupled receptor signaling in cancer. Current Opinion in Cell Biology, 27: 126-135.
Pandurangan M. et al. (2016). In vitro therapeutic potential of TiO2 nanoparticles against human cervical carcinoma cells. Biol. Trace. Elem. Res., 171: 293-300.
Piccinno F. et al. (2012). Industrial production quantities and uses of ten engineered nanomaterials in Europe and the world. Journal Nanoparticles Res., 14: 1109.
Rollerova E. et al. (2015). Titanium dioxide nanoparticles: Some aspects of toxicity/ focus on the development. Endocr Requl, 49(2): 97-112.
Roy, R., Singh, S. K., Das, M., Tripathi, A. y Dwivedi, P. D. (2014). Toll‐like receptor 6 mediated inflammatory and functional responses of zinc oxide nanoparticles primed macrophages. Immunology, 142(3): 453-464.
Setyawati M. I., Yuan X., Xie J., Leong D. T. (2014). The influence of lysosomal stability of silver nanomaterials on their toxicity to human cells. Biomaterials, 35(25): 6707-6715.
Shang Li, Nienhaus Karin y Nienhaus Gerd Ulrich (2014). Engineered nanoparticles interacting with cells: Size matters. Journal of Nanobiotechnology, 12: 5.
Shi–Qiang L., Rong–Rong Z., Meng X., Xiao–Yu S., Si–De Y., Shi–Long W. (2008). Nanotoxicology of TiO2 nanoparticles to erythrocyte in vitro. Food and Chemical Toxicology, 46: 3626-3631.
Venkatakrishnan A. J., Depui Xavier, Lebon Guillaume, Tate Christopher G., Schertler Gebhard., Babu M. Madan (2013). Molecular signatures of G-protein-coupled receptors. Nature, 494: 185-194.
Venter J. C., Adams M. D., Myers E. W., Li P. W., Mural R.J., Sutton G. G., Smith H. O., Yandell M., Evans C. A., Holt R. A. et al. (2001). The sequence of the human genome. Sience, 291: 1304-1351.
Wallin H. et al. (2017). Surface modification does not influence the genotoxic and inflammatory effects of TiO2 nanoparticles after pulmonary exposure by installation in mice. Mutagenesis, 32: 47-57.
Warheit D. B. et al. (2007). Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicology Letters, 171(3): 99-110.
Xie Y., Williams N. G., Tolic A., Chrisler W., Teeguarden J. G., Maddux B., Pounds J. G., Laskin A., Orr G. (2011). Aerosolized ZnO nanoparticles induce toxicity in alveolar Type II epithelial cells at the air-liquid interface. Toxicological Science, 125(2): 450-461.
Záyago L. et al. (2015). ¿Se estudian los riesgos de los nanomateriales en México? Temas de Ciencia y Tecnología, 19(56): 17-27.
Mundo Nano. Revista Interdisciplinaria en Nanociencias y Nanotecnología, editada por la Universidad Nacional Autónoma de México, se distribuye bajo una Licencia Creative Commons Atribución-NoComercial 4.0 Internacional.
Basada en una obra en http://www.mundonano.unam.mx.
